Aurigon Life Science

Aurigon Life Science is a forward-looking, full-service CRO specializing in preclinical and early-stage drug development for oncology and immunology. It positions itself as a 'solutions partner' offering custom preclinical packages, regulatory studies, and strategic consultancy, all embedded within a GLP/GMP/ISO 13485-certified quality framework. The company emphasizes agility, scientific excellence, and a customer-first approach, leveraging an international network of experts. It is also a founding member of the Biosimilars Group and is dedicated to the principles of the 3R-Movement in animal welfare.

Integrated preclinical CRO service platform offering pharmacology, bio-analytics, toxicology, and medical device testing. Utilizes a networked model of best-of-breed experts and operates within a GLP/GMP/ISO 13485-certified quality system.

Aurigon competes in the fragmented preclinical CRO market against large, full-service global CROs (e.g., Charles River, Labcorp, ICON) and smaller, specialized regional players. Its differentiation is based on a high-touch, customized service model, deep focus on oncology/immunology/biosimilars, a strong quality culture, and a commitment to the 3R principles.